|
Mr. Weidong Yin has been the President CEO Secretary and a Director of the Company since September 24 2003. Mr. Yin is also the General Manager of the Company’s subsidiary Sinovac Biotech Co. Ltd. Mr. Weidong Yin has been dedicated to hepatitis research for over 20 years. He is credited with developing the intellectual property that led to the development of the Company’s hepatitis A vaccine. In addition Mr. Yin has been appointed to be the principal investigator by the Chinese Ministry of Science and Technology for many key governmental R&D programs such as Inactivated Hepatitis A vaccine R&D Inactivated SARS vaccine R&D and New Human Influenza Vaccine (H5N1) R&D. He obtained his Masters degree in Business Administration from the Singapore State University
Mr. Weidong Yin
General Manager of Sinovac Biotech Co. Ltd.
CEO of Sinovac Biotech Ltd.
Mr. Yin is the President and CEO of Sinovac. He is also one of founders of Tangshan Yian and Sinovac Biotech Co. Ltd. He has been dedicated to hepatitis research for over 20 years starting as a doctor on epidemiology in Tangshan CDC (Hebei Province). He is credited with developing the intellectual property rights that led to the development of Sinovac’s Hepatitis A Vaccine. Mr. Yin has been appointed to be the principal investigator by the Chinese Ministry of Science and echnology for many key governmental R&D programs such as Inactivated Hepatitis A Vaccine R&D Inactivated SARS Vaccine R&D and New Human Influenza Vaccine (H5N1) R&D. Mr. Yin is instrumental in shaping the Chinese Ministry of Public Health’s policy for prioritizing hepatitis as one of primary diseases to be negated by the country in the next five years.
Dr Yin also serves some public obligations. He is the member of Chinese Foundation for Hepatitis Prevention and Control. He is academic consultant to various Chinese governmental organizations.
Education:
Dr Yin obtained his Medical Degree from the Tangshan Medical School in Hebei Province PRC pursued
advanced study in Virology from the China Institute of Preventive Medical Science and obtained a Master
Degree in Business Administration from the National University of Singapore.
| 